Skip to content

Respiratory Dysregulation and Breathing Training in Anxious Outpatients

Respiratory Dysregulation and Breathing Training in Anxious Outpatients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00108277
Enrollment
92
Registered
2005-04-15
Start date
2005-04-30
Completion date
2010-09-30
Last updated
2015-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety

Keywords

Anxiety, Breathing Training, Respiratory Dysregulation

Brief summary

This study will explore respiratory dysregulation in anxious outpatients and examine the effect of breathing training with biofeedback for those anxious patients.

Detailed description

In clinic testing and outside the clinic testing, we will assess the prevalence of respiratory dysregulation in a sample of 60 non-psychotic, not currently alcohol or drug abusing veteran outpatients from our MHC (Mental Hygiene Clinic) who experience episodic anxiety but who do not qualify and have never qualified for the diagnosis of PD (panic disorder). These patients will be compared to 30 patients who are not clinically anxious. Of these 60 anxious patients, 30 will be randomly assigned to a 4-week course of breathing training assisted by feedback of end-tidal pCO2 levels as an augmentation of their current treatment. They will be compared to 30 who simply will continue with their current treatment (TAU). The breathing training group will receive clinical and physiological assessments immediately before the treatment period, four weeks after the end of the treatment period, and at a 4-month follow-up. The TAU group will be assessed three times at equivalent intervals, and if they wish, may undergo breathing training after the third assessment. Treatment will take place mainly in the first two years, giving us adequate time for follow-up and data analysis. We expect that this therapy will be especially effective for treating anxiety in the patients with substantial respiratory dysregulation.

Interventions

BEHAVIORALBreathing Training-Raise CO2

while breathing 9 breaths per minute, patients are instructed to raise CO2

BEHAVIORALBreathing Training- Lower CO2

while breathing 9 breaths per minute, patients are instructed to lower CO2

Sponsors

US Department of Veterans Affairs
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Patients must be rated 2 or more on both Q1 and Q3, but they must not meet the full criteria for PD as determined by the Anxiety Disorders Interview Schedule for DSM-IV-Lifetime Version (ADIS). * In addition, they must be clinically stable enough that changes in the patients' anxiety levels can be attributed to the breathing training rather than to other new treatment initiatives during the training and 1-month evaluation periods or to spontaneous fluctuations in anxiety levels. Thus, potential participants taking SSRIs or other antidepressants, or benzodiazepines have to have been on a stable dose of these medicines for at least the previous two months.

Exclusion criteria

* Potential participants taking short-acting benzodiazepines such as alprazolam in excess of 2.0 mg/day or the equivalent on any day in the past month are excluded, because improvement might show up only in terms of reduction of medication dosage and not on the evaluation measures planned.

Design outcomes

Primary

MeasureTime frameDescription
Episodic Anxiety Scale1 monthEpisodic Anxiety Scale (EAS) is a modification of the Panic Disorder Severity Scale (Shear et al., 1997) that includes 2 additional questions regarding acute anxiety episodes that may not meet full criteria for a panic attack. The EAS consists of 9 questions, each ranging from 0 (none) to 4 (worst possible). The EAS total score is the sum of all 9 items, such that the minimum total score = 0 (no anxiety symptoms) and maximum total score = 36 (worst possible anxiety symptoms).

Countries

United States

Participant flow

Recruitment details

Participants were recruited from October 2005 to September 2008 from the local VA medical center and surrounding community. Participants were primarily recruited via posted flyers and other public advertisements (e.g., ads in local newspapers).

Participants by arm

ArmCount
Raise CO2
Raise CO2 Breathing Training-Raise CO2: while breathing 9 minutes per minute, patients are instructed to raise CO2
29
Lower CO2
Lower CO2 Breathing Training- Lower CO2: while breathing 9 minutes per minute, patients are instructed to lower CO2
28
Waitlist
Waitlist Treatment as usual
35
Total92

Baseline characteristics

CharacteristicRaise CO2Lower CO2WaitlistTotal
Age, Continuous47.3 years
STANDARD_DEVIATION 13.2
40.6 years
STANDARD_DEVIATION 12.2
49.9 years
STANDARD_DEVIATION 10.9
45.9 years
STANDARD_DEVIATION 12.1
Episodic Anxiety Scale15.5 units on a scale
STANDARD_DEVIATION 3.44
15.7 units on a scale
STANDARD_DEVIATION 4.53
16.1 units on a scale
STANDARD_DEVIATION 3.23
15.8 units on a scale
STANDARD_DEVIATION 3.73
Race/Ethnicity, Customized
Other
14 participants12 participants18 participants44 participants
Race/Ethnicity, Customized
White
15 participants16 participants17 participants48 participants
Sex: Female, Male
Female
16 Participants20 Participants25 Participants61 Participants
Sex: Female, Male
Male
13 Participants8 Participants10 Participants31 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 290 / 280 / 35
serious
Total, serious adverse events
0 / 290 / 280 / 35

Outcome results

Primary

Episodic Anxiety Scale

Episodic Anxiety Scale (EAS) is a modification of the Panic Disorder Severity Scale (Shear et al., 1997) that includes 2 additional questions regarding acute anxiety episodes that may not meet full criteria for a panic attack. The EAS consists of 9 questions, each ranging from 0 (none) to 4 (worst possible). The EAS total score is the sum of all 9 items, such that the minimum total score = 0 (no anxiety symptoms) and maximum total score = 36 (worst possible anxiety symptoms).

Time frame: 1 month

ArmMeasureValue (MEAN)Dispersion
Raise CO2Episodic Anxiety Scale8.1 units on a scaleStandard Deviation 2.73
Lower CO2Episodic Anxiety Scale9.0 units on a scaleStandard Deviation 3.89
WaitlistEpisodic Anxiety Scale14.3 units on a scaleStandard Deviation 3.67

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026